Matches in Wikidata for { <http://www.wikidata.org/entity/Q65470833> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q65470833 description "clinical trial" @default.
- Q65470833 description "ensayu clínicu" @default.
- Q65470833 description "klinisch onderzoek" @default.
- Q65470833 description "клінічне випробування" @default.
- Q65470833 name "Immunogenicity and Safety of GlaxoSmithKline Biologicals' Huma Papillomavirus (HPV) Vaccine 580299 in Healthy Females 15 - 25 Years of Age" @default.
- Q65470833 name "Immunogenicity and Safety of GlaxoSmithKline Biologicals' Huma Papillomavirus" @default.
- Q65470833 type Item @default.
- Q65470833 label "Immunogenicity and Safety of GlaxoSmithKline Biologicals' Huma Papillomavirus (HPV) Vaccine 580299 in Healthy Females 15 - 25 Years of Age" @default.
- Q65470833 label "Immunogenicity and Safety of GlaxoSmithKline Biologicals' Huma Papillomavirus" @default.
- Q65470833 prefLabel "Immunogenicity and Safety of GlaxoSmithKline Biologicals' Huma Papillomavirus (HPV) Vaccine 580299 in Healthy Females 15 - 25 Years of Age" @default.
- Q65470833 prefLabel "Immunogenicity and Safety of GlaxoSmithKline Biologicals' Huma Papillomavirus" @default.
- Q65470833 P1132 Q65470833-FA1CEEB1-5DD2-4D66-9813-059567F60D55 @default.
- Q65470833 P1476 Q65470833-EEC8A801-32E6-4811-8023-D6C4BCBCE9B0 @default.
- Q65470833 P17 Q65470833-6AFBA394-CA0D-41FC-87ED-00BCAAE43DF5 @default.
- Q65470833 P17 Q65470833-895A2301-08DC-467C-953D-F3C714B96ECD @default.
- Q65470833 P17 Q65470833-D3DBFEB9-1BFA-49D1-8013-319BC4C4EB43 @default.
- Q65470833 P2899 Q65470833-2DD150C7-8801-451B-8C71-7555BB4474F6 @default.
- Q65470833 P3098 Q65470833-ECE74610-D698-472A-B93D-18468C98A218 @default.
- Q65470833 P31 Q65470833-CE335A79-08E2-406A-B0FC-8007389F7C0E @default.
- Q65470833 P4135 Q65470833-796FA718-1122-4632-BA11-6334777A7A13 @default.
- Q65470833 P580 Q65470833-DF4807CE-13F9-47EC-AE55-DEBCBEB977F7 @default.
- Q65470833 P582 Q65470833-FCC43345-9EB7-4FEC-B7DF-E205B9271CEE @default.
- Q65470833 P6099 Q65470833-EFB8750A-B72E-44AB-9773-37EBED21C420 @default.
- Q65470833 P6153 Q65470833-6CB885CA-93AE-4F15-981E-1CE43D3C94BC @default.
- Q65470833 P8363 Q65470833-593DE197-B40F-4A71-8B52-A54543EEA75F @default.
- Q65470833 P859 Q65470833-928F245A-F3A7-4273-A0E1-41176A0BC36C @default.
- Q65470833 P1132 "+805" @default.
- Q65470833 P1476 "Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' HPV Vaccine GSK580299 Administered According to an Alternative Dosing Schedule as Compared to the Standard Dosing Schedule in Young Female Subjects Aged 15-25 Years" @default.
- Q65470833 P17 Q214 @default.
- Q65470833 P17 Q218 @default.
- Q65470833 P17 Q38 @default.
- Q65470833 P2899 "+15" @default.
- Q65470833 P3098 "NCT00552279" @default.
- Q65470833 P31 Q30612 @default.
- Q65470833 P4135 "+25" @default.
- Q65470833 P580 "2007-11-12T00:00:00Z" @default.
- Q65470833 P582 "2009-02-26T00:00:00Z" @default.
- Q65470833 P6099 Q42824827 @default.
- Q65470833 P6153 Q212322 @default.
- Q65470833 P8363 Q78089383 @default.
- Q65470833 P859 Q212322 @default.